AR033896A1 - Preparaciones granuladas de gaboxadol. - Google Patents

Preparaciones granuladas de gaboxadol.

Info

Publication number
AR033896A1
AR033896A1 ARP020101839A ARP020101839A AR033896A1 AR 033896 A1 AR033896 A1 AR 033896A1 AR P020101839 A ARP020101839 A AR P020101839A AR P020101839 A ARP020101839 A AR P020101839A AR 033896 A1 AR033896 A1 AR 033896A1
Authority
AR
Argentina
Prior art keywords
gaboxadol
granulated
granulated preparations
preparation
preparations
Prior art date
Application number
ARP020101839A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR033896A1 publication Critical patent/AR033896A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Producto granulado que contiene gaboxadol como sal de adición de ácido, con un proceso de granulación en fusión para la preparación del mismo y con formas de dosificación unitaria farmacéuticas macizas preparadas con dicha preparación granulada de gaboxadol.
ARP020101839A 2001-05-21 2002-05-17 Preparaciones granuladas de gaboxadol. AR033896A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200100817 2001-05-21

Publications (1)

Publication Number Publication Date
AR033896A1 true AR033896A1 (es) 2004-01-07

Family

ID=8160520

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101839A AR033896A1 (es) 2001-05-21 2002-05-17 Preparaciones granuladas de gaboxadol.

Country Status (26)

Country Link
US (1) US20040157876A1 (es)
EP (1) EP1389091A1 (es)
JP (1) JP2004530695A (es)
KR (1) KR20030097890A (es)
CN (1) CN1511026A (es)
AR (1) AR033896A1 (es)
AU (1) AU2002338855B2 (es)
BG (1) BG108441A (es)
BR (1) BR0209834A (es)
CA (1) CA2447603A1 (es)
CZ (1) CZ20033269A3 (es)
EA (2) EA009731B1 (es)
HR (1) HRP20030950A2 (es)
HU (1) HUP0400051A2 (es)
IL (1) IL158733A0 (es)
IS (1) IS7020A (es)
ME (1) MEP6308A (es)
MX (1) MXPA03010596A (es)
NO (1) NO20035146L (es)
NZ (1) NZ547636A (es)
PL (1) PL366541A1 (es)
SK (1) SK15542003A3 (es)
UA (1) UA80092C2 (es)
WO (1) WO2002094225A1 (es)
YU (1) YU92103A (es)
ZA (1) ZA200308594B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7405000A (en) * 1999-09-28 2001-04-30 H. Lundbeck A/S Melt granulated composition and modified release dosage form prepared from said composition
ES2341004T3 (es) 2003-06-25 2010-06-14 H. Lundbeck A/S Gaboxadol para tratar la depresion y otros trastornos afectivos.
TW200528098A (en) * 2003-12-18 2005-09-01 Lundbeck & Co As H Treatment of insomnia in human patients
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
WO2006083682A2 (en) 2005-01-28 2006-08-10 H.Lundbeck A/S Polymorphic forms of a gabaa agonist
WO2006118897A1 (en) * 2005-04-29 2006-11-09 H.Lundbeck A/S Acid and base salt forms of gaboxadol
EP2374459A1 (en) * 2008-05-30 2011-10-12 Psychogenics Inc. Treatment for neurological and mental disorders
JP2012501301A (ja) * 2008-09-01 2012-01-19 ハー・ルンドベック・アクチエゼルスカベット ガボキサドールおよびｐａｔ１阻害薬またはｏａｔ阻害薬を含む医薬組成物
EP2790729A4 (en) * 2011-12-12 2015-08-12 Orbis Biosciences Inc PARTICULATE FORMULATIONS WITH DELAYED RELEASE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315934A (en) * 1979-09-24 1982-02-16 Sandoz Ltd. Organic compounds
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
AU7405000A (en) * 1999-09-28 2001-04-30 H. Lundbeck A/S Melt granulated composition and modified release dosage form prepared from said composition
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same

Also Published As

Publication number Publication date
US20040157876A1 (en) 2004-08-12
EP1389091A1 (en) 2004-02-18
ZA200308594B (en) 2004-11-04
UA80092C2 (en) 2007-08-27
HUP0400051A2 (hu) 2004-04-28
KR20030097890A (ko) 2003-12-31
CA2447603A1 (en) 2002-11-28
YU92103A (sh) 2006-05-25
JP2004530695A (ja) 2004-10-07
IL158733A0 (en) 2004-05-12
IS7020A (is) 2003-11-10
MEP6308A (xx) 2010-02-10
EA200700703A1 (ru) 2007-08-31
BR0209834A (pt) 2004-06-15
HRP20030950A2 (en) 2005-08-31
NO20035146D0 (no) 2003-11-19
SK15542003A3 (sk) 2004-05-04
EA009731B1 (ru) 2008-02-28
NO20035146L (no) 2003-11-19
MXPA03010596A (es) 2004-03-09
PL366541A1 (en) 2005-02-07
EA200301282A1 (ru) 2004-04-29
NZ547636A (en) 2008-03-28
BG108441A (en) 2005-02-28
WO2002094225A1 (en) 2002-11-28
AU2002338855B2 (en) 2007-08-16
CZ20033269A3 (en) 2004-03-17
CN1511026A (zh) 2004-07-07

Similar Documents

Publication Publication Date Title
MXPA03008419A (es) Amidas de acido antranilico, metodo para su produccion, su uso como agentes anti-arritmia, y preparaciones farmaceuticas de las mismas.
AU2002227931A1 (en) Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as medicament, and pharmaceutical preparations containing these compounds
AU2002338494A1 (en) Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
BR0015048A (pt) Sal farmacêutico, medicamento, uso de pelo menos um sal de tramadol e formas de apresentação
BR0207726A (pt) Sais farmacêuticos
DE122011100049I1 (de) Stabile pharmazeutische Losungsformulierungen fur unter Druck stehende Inhaliergerate fur die Verabreichung abgemessener Dosen.
HRP20090194T1 (en) Dry granulated composition comprising emtricitabine and tenofovir df
WO2005051317A3 (en) Substituted imidazo ring systems and methods
MXPA03004386A (es) Compuestos bis-arilo sustituidos en la posicion orto y meta, procesos para su preparacion, su uso como medicamento, y las preparaciones farmaceuticas que los contienen.
ATE396712T1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
AR021074A1 (es) COMPOSICIoN FARMACÉUTICA DE MOXIFLOXACINA, PROCEDIMIENTO PARA SU PRODUCCIoN, Y USO DE DICHA COMPOSICIoN PARA PREPARAR UN MEDICAMENTO ANTIBACTERIANO.
NO20031273L (no) Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme
DE50101364D1 (de) Ortho substituierte anthranilsäureamide und deren verwendung als arzneimittel
MA27147A1 (fr) 4-phenyltetrahydro-isoquinoleines substituees, procede pour leur preparation, leur utilisation en tant que medicament, et medicament les contenant
FR2850576B1 (fr) Composition comprenant un melange de principes actifs, et procede de preparation
BRPI0518789A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
AR033896A1 (es) Preparaciones granuladas de gaboxadol.
BRPI0518790A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
IS6511A (is) Lyfjaefnablöndur sem innihalda sykurfitusýru estera til að stýra losun á virkum innihaldsefnum
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
IL163951A0 (en) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
AR029590A1 (es) Antibacterianos
ZA200506992B (en) Fibrate tablet and method for the production thereof

Legal Events

Date Code Title Description
FB Suspension of granting procedure